Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)

Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X) Publisher Pubmed

Mahdieh N¹ ; Rabbani A² ; Firouzi A² ; Zahedmehr A² ; Hoseinimoghaddam M¹ ; Saedi S² ; Sanati H² ; Basiri H² ; Noohi F² ; Rabbani B^{1, 3} ; Maleki M¹

Source: Cardiovascular Toxicology Published:2018

Abstract

Related Docs

View other Related Docs

1. Correction To: Generation of Liver Disease-Specific Induced Pluripotent Stem Cells Along With Efficient Differentiation to Functional Hepatocyte-Like Cells (Stem Cell Reviews and Reports, (2010), 6, 4, (622-632), 10.1007/S12015-010-9189-3), Stem Cell Reviews and Reports (2021)

2. Early Roux-En-Y Gastrojejunostomy As a Safe and Feasible Treatment of Post Sleeve Gastrectomy Leak, Obesity Surgery (2021)

3. Outcomes of Laparoscopic One-Anastomosis Gastric Bypass (Oagb) in Patients With Morbid Obesity and Multiple Sclerosis, Obesity Surgery (2021)

Experts (# of related papers)

View all Related Experts

Khosrow Najjari (2)

Mohammad Talebpour (2)

Style	Citing Format
MLA	Mahdieh N, et al.. "Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)." Cardiovascular Toxicology, vol. 18, no. 5, 2018, pp. 492-.
APA	Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, Basiri H, Noohi F, Rabbani B, Maleki M (2018). Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X). Cardiovascular Toxicology, 18(5), 492-.
Chicago	Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, et al.. "Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)." Cardiovascular Toxicology 18, no. 5 (2018): 492-.
Harvard	Mahdieh N et al. (2018) 'Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)', Cardiovascular Toxicology, 18(5), pp. 492-.
Vancouver	Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, et al.. Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X). Cardiovascular Toxicology. 2018;18(5):492-.
BibTex	@article{ author = {Mahdieh N and Rabbani A and Firouzi A and Zahedmehr A and Hoseinimoghaddam M and Saedi S and Sanati H and Basiri H and Noohi F and Rabbani B and Maleki M}, title = {Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)}, journal = {Cardiovascular Toxicology}, volume = {18}, number = {5}, pages = {492-}, year = {2018} }
RIS	TY - JOUR AU - Mahdieh N AU - Rabbani A AU - Firouzi A AU - Zahedmehr A AU - Hoseinimoghaddam M AU - Saedi S AU - Sanati H AU - Basiri H AU - Noohi F AU - Rabbani B AU - Maleki M TI - Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X) JO - Cardiovascular Toxicology VL - 18 IS - 5 SP - 492 EP - PY - 2018 ER -

Style

Citing Format

MLA

Mahdieh N, et al.. "Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)." Cardiovascular Toxicology, vol. 18, no. 5, 2018, pp. 492-.

APA

Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, Basiri H, Noohi F, Rabbani B, Maleki M (2018). Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X). Cardiovascular Toxicology, 18(5), 492-.

Chicago

Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, et al.. "Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)." Cardiovascular Toxicology 18, no. 5 (2018): 492-.

Harvard

Mahdieh N et al. (2018) 'Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)', Cardiovascular Toxicology, 18(5), pp. 492-.

Vancouver

Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, et al.. Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X). Cardiovascular Toxicology. 2018;18(5):492-.

BibTex

@article{ author = {Mahdieh N and Rabbani A and Firouzi A and Zahedmehr A and Hoseinimoghaddam M and Saedi S and Sanati H and Basiri H and Noohi F and Rabbani B and Maleki M}, title = {Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)}, journal = {Cardiovascular Toxicology}, volume = {18}, number = {5}, pages = {492-}, year = {2018} }

RIS

TY - JOUR
AU - Mahdieh N
AU - Rabbani A
AU - Firouzi A
AU - Zahedmehr A
AU - Hoseinimoghaddam M
AU - Saedi S
AU - Sanati H
AU - Basiri H
AU - Noohi F
AU - Rabbani B
AU - Maleki M
TI - Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention (Cardiovascular Toxicology, (2018), 18, 5, (482-491), 10.1007/S12012-018-9459-X)
JO - Cardiovascular Toxicology
VL - 18
IS - 5
SP - 492
EP -
PY - 2018
ER -

Science Communicator Platform

Authors

Abstract